These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease. Kurnick JE, White M, Ware DE, Robinson WA. Cancer Chemother Rep; 1975 Sep; 59(6):1147-50. PubMed ID: 56989 [Abstract] [Full Text] [Related]
9. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas. Chang P, Levine MA, Wiernik PH, Walker MD. Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946 [Abstract] [Full Text] [Related]
13. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. Omura GA, Shingleton HM, Creasman WT, Blessing JA, Boronow RC. Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400 [No Abstract] [Full Text] [Related]
15. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO, Lavin PT, Moertel CG. Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [Abstract] [Full Text] [Related]
16. Sequential and combination chemotherapy of advanced gastric cancer. Moertel CG, Mittelman JA, Bakemeier RF, Engstrom P, Hanley J. Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891 [Abstract] [Full Text] [Related]
17. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy. Cedermark BJ, Didolkar MS, Elias EG. Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977 [Abstract] [Full Text] [Related]
18. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR. Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [Abstract] [Full Text] [Related]
19. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ, Berger M. Arzneimittelforschung; 1981 May; 31(2):303-5. PubMed ID: 7194646 [Abstract] [Full Text] [Related]
20. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up. Cruz AB, Metter G, Armstrong DM, Aust JB, Fletcher WS, Wilson WL, Richardson JD. Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]